Why Buyer Underwriting Is Slowing Healthcare Deals in Q2

If your deal is taking longer to close this quarter, you’re not alone.

Across the healthcare real estate space—from behavioral health to outpatient medical to senior living—we’re seeing one consistent trend: buyer underwriting is getting heavier.

Gone are the days of quick reviews and soft commitments. Today’s buyers are diving deep. They’re asking for:

→ Detailed financials from operators

→ Verification of licensing and compliance status

→ Market-specific comp support

→ Updated capex schedules

→ Proof of patient volume stability

And it’s not just institutional capital. Even regional buyers and private investors are pushing for more data before signing off.

Why? Because between tighter lending, lingering macro uncertainty, and rising operational costs, everyone wants to validate performance before committing capital.

For owners and brokers, this means one thing:

Be ready.

The more proactive you are with documentation, data, and valuation rationale, the smoother the process will be. If you’re selling, get ahead of the underwriting—don’t wait for the buyer to start the process.

From a valuation standpoint, it’s also shifting how we look at value. Buyers aren’t just pricing assets—they’re pricing risk. And that risk is tied to everything from tenant strength to licensing complexity to local demand dynamics.

Q2 isn’t a slowdown. It’s a sift. The capital is still out there—it’s just more cautious, and it’s asking smarter questions.

📅 Book a call if you’re prepping for a deal or need a valuation that speaks the language of today’s buyers.

📬 Subscribe to the newsletter for grounded insight on what’s actually happening in healthcare real estate deals this quarter.